TMO EPM / Hemato H9J

podcast

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julh...

Health & Fitness 88 recordings 2023 → today Every two weeks updated 4 days ago
Search in TMO EPM / Hemato H9J →

All episodes

41–60 of 88
48 - Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma contributed by Lukas · Mar 16, 2025
47 - Dar­a­tum­umab or Active Monitoring for High-Risk Smoldering Multiple Myeloma contributed by Lukas · Mar 11, 2025
46 - Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study contributed by Lukas · Dec 29, 2024
45 - Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma contributed by Lukas · Dec 26, 2024
44 - Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML contributed by Lukas · Dec 23, 2024
43 - Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma contributed by Lukas · Nov 27, 2024
42 - Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21) contributed by Lukas · Nov 23, 2024
41 - An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease contributed by Lukas · Nov 1, 2024
40 - Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission contributed by Lukas · Sep 27, 2024
39 - Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors contributed by Lukas · Sep 25, 2024
38 - Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma contributed by Lukas · Sep 19, 2024
37 - Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults contributed by Lukas · Aug 24, 2024
36 - Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma contributed by Lukas · Aug 16, 2024
35 - A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia contributed by Lukas · Aug 5, 2024
34 - Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission contributed by Lukas · Jul 27, 2024
33 - Asciminib in Newly Diagnosed Chronic Myeloid Leukemia contributed by Lukas · Jul 14, 2024
32 - The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial contributed by Lukas · Jul 12, 2024
31 - Remission induction vs immediate allogeneic HSCT for patients with relapsed or poor responsive AML (ASAP): a randomised, open-label, phase 3, non-inferiority trial contributed by Lukas · Jul 5, 2024
30 - Ibrutinib combined with immunochemotherapy with or without ASCT vs immunochemotherapy and ASCT in previously untreated patients with mantle cell lymphoma (TRIANGLE) contributed by Lukas · Jul 3, 2024
29 - Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT contributed by Lukas · May 27, 2024
page 3 of 5 «« ← Prev Next → »»

Activity

module · podcast

7 episodes · last 30 days

Wed 6Sun 6Fri 4

Episodes per week over the last six months.

About

module · podcast

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

TMO EPM / Hemato H9J podcasters.spotify.com/pod/show/vin355cius-campos-de-moll RSS Apple